These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 36889420

  • 1. Yi-Shen-Xie-Zhuo formula alleviates cisplatin-induced AKI by regulating inflammation and apoptosis via the cGAS/STING pathway.
    Qi J, Luo Q, Zhang Q, Wu M, Zhang L, Qin L, Xue Q, Nie X.
    J Ethnopharmacol; 2023 Jun 12; 309():116327. PubMed ID: 36889420
    [Abstract] [Full Text] [Related]

  • 2. Myricetin-Loaded Nanomicelles Protect against Cisplatin-Induced Acute Kidney Injury by Inhibiting the DNA Damage-cGAS-STING Signaling Pathway.
    Qi X, Wang J, Fei F, Gao X, Wu X, Shi D, Guo C.
    Mol Pharm; 2023 Jan 02; 20(1):136-146. PubMed ID: 36326450
    [Abstract] [Full Text] [Related]

  • 3. Baicalein-loaded silk fibroin peptide nanofibers protect against cisplatin-induced acute kidney injury: Fabrication, characterization and mechanism.
    Liu S, Gao X, Wang Y, Wang J, Qi X, Dong K, Shi D, Wu X, Guo C.
    Int J Pharm; 2022 Oct 15; 626():122161. PubMed ID: 36058409
    [Abstract] [Full Text] [Related]

  • 4. Mitochondrial Damage Causes Inflammation via cGAS-STING Signaling in Acute Kidney Injury.
    Maekawa H, Inoue T, Ouchi H, Jao TM, Inoue R, Nishi H, Fujii R, Ishidate F, Tanaka T, Tanaka Y, Hirokawa N, Nangaku M, Inagi R.
    Cell Rep; 2019 Oct 29; 29(5):1261-1273.e6. PubMed ID: 31665638
    [Abstract] [Full Text] [Related]

  • 5. Ursodeoxycholic acid protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction through acting on ALDH1L2.
    Yang Y, Liu S, Gao H, Wang P, Zhang Y, Zhang A, Jia Z, Huang S.
    Free Radic Biol Med; 2020 May 20; 152():821-837. PubMed ID: 32004633
    [Abstract] [Full Text] [Related]

  • 6. The novel STING antagonist H151 ameliorates cisplatin-induced acute kidney injury and mitochondrial dysfunction.
    Gong W, Lu L, Zhou Y, Liu J, Ma H, Fu L, Huang S, Zhang Y, Zhang A, Jia Z.
    Am J Physiol Renal Physiol; 2021 Apr 01; 320(4):F608-F616. PubMed ID: 33615891
    [Abstract] [Full Text] [Related]

  • 7. Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells treated by cisplatin with different doses and exposure times.
    Oh SM, Park G, Lee SH, Seo CS, Shin HK, Oh DS.
    BMC Complement Altern Med; 2017 Dec 19; 17(1):544. PubMed ID: 29258482
    [Abstract] [Full Text] [Related]

  • 8. Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosis.
    Xu Z, Zhang M, Wang W, Zhou S, Yu M, Qiu X, Jiang S, Wang X, Tang C, Li S, Wang CH, Zhu R, Peng WX, Zhao L, Fu X, Patzak A, Persson PB, Zhao L, Mao J, Shu Q, Lai EY, Zhang G.
    Toxicol Appl Pharmacol; 2023 Aug 15; 473():116595. PubMed ID: 37328118
    [Abstract] [Full Text] [Related]

  • 9. Fucoidan-proanthocyanidins nanoparticles protect against cisplatin-induced acute kidney injury by activating mitophagy and inhibiting mtDNA-cGAS/STING signaling pathway.
    Gao X, Yin Y, Liu S, Dong K, Wang J, Guo C.
    Int J Biol Macromol; 2023 Aug 01; 245():125541. PubMed ID: 37355076
    [Abstract] [Full Text] [Related]

  • 10. An herbal formulation "Shenshuaifu Granule" alleviates cisplatin-induced nephrotoxicity by suppressing inflammation and apoptosis through inhibition of the TLR4/MyD88/NF-κB pathway.
    Jin X, He R, Liu J, Wang Y, Li Z, Jiang B, Lu J, Yang S.
    J Ethnopharmacol; 2023 Apr 24; 306():116168. PubMed ID: 36646160
    [Abstract] [Full Text] [Related]

  • 11. Flavonoid derivative DMXAA attenuates cisplatin-induced acute kidney injury independent of STING signaling.
    Lu L, Liu W, Li S, Bai M, Zhou Y, Jiang Z, Jia Z, Huang S, Zhang A, Gong W.
    Clin Sci (Lond); 2023 Mar 31; 137(6):435-452. PubMed ID: 36815438
    [Abstract] [Full Text] [Related]

  • 12. β-Hydroxybutyrate against Cisplatin-Induced acute kidney injury via inhibiting NLRP3 inflammasome and oxidative stress.
    Luo S, Yang M, Han Y, Zhao H, Jiang N, Li L, Chen W, Li C, Yang J, Liu Y, Liu C, Zhao C, Sun L.
    Int Immunopharmacol; 2022 Oct 31; 111():109101. PubMed ID: 35940076
    [Abstract] [Full Text] [Related]

  • 13. [Effect and mechanism of Jiedu Huoxue Decoction in regulating YAP/ACSL4 pathway to inhibit ferroptosis in treatment of acute kidney injury].
    Cheng R, Tian RM, Huang LH, Wang XW, Guo S, Wu AJ, Li C, Chen J, Li SJ, Chen M, Mao W, Xu P.
    Zhongguo Zhong Yao Za Zhi; 2024 Jan 31; 49(1):151-161. PubMed ID: 38403348
    [Abstract] [Full Text] [Related]

  • 14. Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury.
    Yang Y, Yu X, Zhang Y, Ding G, Zhu C, Huang S, Jia Z, Zhang A.
    Clin Sci (Lond); 2018 Apr 16; 132(7):825-838. PubMed ID: 29581249
    [Abstract] [Full Text] [Related]

  • 15. The protective role of Achyranthes aspera extract against cisplatin-induced nephrotoxicity by alleviating oxidative stress, inflammation, and PANoptosis.
    Lin SY, Chang CL, Liou KT, Kao YK, Wang YH, Chang CC, Kuo TBJ, Huang HT, Yang CCH, Liaw CC, Shen YC.
    J Ethnopharmacol; 2024 Jan 30; 319(Pt 1):117097. PubMed ID: 37648176
    [Abstract] [Full Text] [Related]

  • 16. Shenqi Fuzheng Injection Reduces Cisplatin-Induced Kidney Injury via cGAS/STING Signaling Pathway in Breast Cancer Mice Model.
    Ma Y, Bai B, Liu D, Shi R, Zhou Q.
    Breast Cancer (Dove Med Press); 2024 Jan 30; 16():451-469. PubMed ID: 39165276
    [Abstract] [Full Text] [Related]

  • 17. Asiatic acid protects against cisplatin-induced acute kidney injury via anti-apoptosis and anti-inflammation.
    Yang C, Guo Y, Huang TS, Zhao J, Huang XJ, Tang HX, An N, Pan Q, Xu YZ, Liu HF.
    Biomed Pharmacother; 2018 Nov 30; 107():1354-1362. PubMed ID: 30257350
    [Abstract] [Full Text] [Related]

  • 18. Intervention of mitochondrial activity attenuates cisplatin-induced acute kidney injury.
    Yang Y, Fu Y, Wang P, Liu S, Sha Y, Zhang Y, Zhang A, Jia Z, Ding G, Huang S.
    Int Urol Nephrol; 2019 Jul 30; 51(7):1207-1218. PubMed ID: 31020626
    [Abstract] [Full Text] [Related]

  • 19. Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation.
    Yang Q, Zang HM, Xing T, Zhang SF, Li C, Zhang Y, Dong YH, Hu XW, Yu JT, Wen JG, Jin J, Li J, Zhao R, Ma TT, Meng XM.
    Phytomedicine; 2021 May 30; 85():153541. PubMed ID: 33773190
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.